Serum sickness-like reaction due to Infliximab reintroduction during pregnancy

Journal of Crohn's and Colitis

Volumn 7, Issue 5, 2013, Pages

  Grosen, Anne ^a   Julsgaard, Mette ^a   Christensen, Lisbet Ambrosius ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; INFLIXIMAB; MESALAZINE; METHYLPREDNISOLONE; OSELTAMIVIR; PREDNISOLONE; STEROID;

ADULT; ARTHRALGIA; BLOOD CHEMISTRY; BLOOD CULTURE; CASE REPORT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ENDOSCOPY; FEMALE; FEVER; GESTATIONAL AGE; HUMAN; LETTER; MYALGIA; PREGNANT WOMAN; PRIORITY JOURNAL; RELAPSE; REMISSION; RISK REDUCTION; SERUM SICKNESS; STEROID THERAPY; TREATMENT DURATION; ULCERATIVE COLITIS; URINE CULTURE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SERUM SICKNESS;

EID: 84875628362     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.10.006     Document Type: Letter

References (6)

1. Kugathasan S., Levy M.B., Saeian K., Vasilopoulos S., Kim J.P., Prajapati D., et al. Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction. Am J Gastroenterol 2002, 97:1408-1414.
2. van der Woude C.J., Kolacek S., Dotan I., Oresland T., Vermeire S., Munkholm P., et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010, 4:493-510.
3. Travis S.P., Stange E.F., Lemann M., Oresland T., Bemelman W.A., Chowers Y., et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008, 2:24-62.
4. Simons F.E., Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012, 130:597-606.
5. Mahadevan U., Cucchiara S., Hyams J.S., Steinwurz F., Nuti F., Travis S.P., et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol 2011, 106:214-223.
6. Vermeire S., Noman M., Van A.G., Baert F., D'Haens G., Rutgeerts P. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. Gut 2007, 56:1226-1231.